Two recovering former stars
Two beaten-down stocks are showing signs of life, and in both cases, a hard-fought push into the US market is the reason why.
Investment analysis, share recommendations, and market insights.
Two beaten-down stocks are showing signs of life, and in both cases, a hard-fought push into the US market is the reason why.
For the week ending Friday 31 July 2026, FNArena recorded five upgrades and 12 downgrades in ratings for individual ASX-listed stocks from seven brokers monitored daily.
Michael Gable, Managing Director of Fairmont Equities, says ANZ has put in a bottoming pattern, having broken its downtrend, and is likely to rally towards $40.
What healthcare ETFs are available? Is Northern Star Resources (NST) out of the woods? After CSL's strong rally, what upside do the brokers foresee? How can I participate in RIO's dividend re-investment plan?
Weakness in defence ETFs this year could be an opportunity for long-term investors.
Running your own super fund comes with more than paperwork. It comes with a report card, and it's time to see how your numbers stack up.
Drones have gone from novelty gadgets to front-line weapons in barely a decade, and the money is following fast. Here's where the ASX fits into that story.
Raymond Chan, Private Client Adviser and Head of Asian Desk at Morgans, explains why Morgans' stock of the week is Amcor (AMC), with a constructive medium-term outlook.
Tech stocks have had a rough 13 months, battered by AI fears, Iran war nerves and rate anxiety. I look at ATEC, the ASX tech ETF I've been backing, to ask whether the patient investor is about to be rewarded.
For the week ending Friday 24 July 2026, FNArena recorded nine upgrades and 12 downgrades in ratings for individual ASX-listed stocks from seven brokers monitored daily.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.